Trevi Therapeutics

Trevi Therapeutics

Trevi Therapeutics

Trevi Therapeutics is a drug development company founded in 2011 focused on developing Nalbuphine ER for the severe chronic itching condition known as pruritus.
Founded
2011
Raised
$98.1M
Follow us
Alexa global traffic share